Hair follicle apoptosis and Bcl-2.

[1]  J. Michelet,et al.  Androgenetic alopecia and microinflammation , 2000, International journal of dermatology.

[2]  T. Fischer,et al.  Stinging and rosacea. , 1999, Acta dermato-venereologica.

[3]  V H Price,et al.  Treatment of hair loss. , 1999, The New England journal of medicine.

[4]  Bonafé,et al.  Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells , 1998, The British journal of dermatology.

[5]  K. Kaufman.  ANDROGEN METABOLISM AS IT AFFECTS HAIR GROWTH IN ANDROGENETIC ALOPECIA , 1996 .

[6]  R. Hoffman,et al.  The feasibility of targeted selective gene therapy of the hair follicle , 1995, Nature Medicine.

[7]  D A Whiting,et al.  Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. , 1993, Journal of the American Academy of Dermatology.

[8]  A. Kligman,et al.  Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis , 1992, The British journal of dermatology.

[9]  T. Sun,et al.  Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis , 1990, Cell.

[10]  K. thestrup-pedersen,et al.  [Red scalp. A previously undescribed disease of the scalp?]. , 1987, Ugeskrift for laeger.

[11]  S. Worel,et al.  Substance P (SP) in innervated and non-innervated blood vessels in the skin of patients with symptomatic scalp. , 1999, Experimental dermatology.

[12]  R. Hoffman.  Topical liposome targeting of dyes, melanins, genes, and proteins selectively to hair follicles. , 1998, Journal of drug targeting.

[13]  N. Nikkels‐Tassoudji,et al.  Improvement in the inflammatory aspect of androgenetic alopecia. A pilot study with an antimicrobial lotion , 1996 .